Alkermes Inc – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 06/30/11 Q1

ended 03/31/11 FY 2011 – amended

ended 03/31/11 FY 2011

ended 12/31/10 Q3

ended 09/30/10 Q2

Prospectuses and Registrations Filter

Removal from listing

Securities registration termination

Business combination disclosure

Business combination disclosure

Business combination disclosure

Ownership Filter

Price T Rowe Associates Inc

Price T Rowe Associates Inc

Price T Rowe Associates Inc

Price T Rowe Associates Inc

Price T Rowe Associates Inc

News Filter

ANNOUNCES SHAREHOLDER VOTE IN FAVOR OF MERGER WITH ELAN DRUG TECHNOLOGIES — 99.9% of Votes Cast Were in Favor of Merger — — Transaction Expected to Close on Sept. 16, 2011 —

Reports First Quarter Fiscal 2012 Financial Results

Provides Outlook for Alkermes PLC and Update on Advancing Product Portfolio at Analyst and Investor Day

Change in Directors, Officers or Compensation, Financial Statements or Exhibits

Reports Financial Results for Fiscal 2011 and Provides Financial Expectations for Fiscal 2012

Proxies Filter

Proxy related to merger

Additional info about upcoming vote

Additional info about upcoming vote

Additional info about upcoming vote

Additional info about upcoming vote

Other Filter

Confidential treatment order

Confidential treatment order

Confidential treatment order

Confidential treatment order

Confidential treatment order